Last reviewed · How we verify
NCT04514718
Low Energy HoLEP on IPSS
NA trial testing Holmium laser in Prostate Hyperplasia in 90 participants. Status unknown.
31 December 2020
Quick facts
| Lead sponsor | Seoul National University Hospital |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 90 |
| Start date | 24 August 2020 |
| Primary completion | 31 December 2020 |
| Estimated completion | 31 December 2020 |
Drugs / interventions tested
- Holmium laser
Conditions studied
- Prostate Hyperplasia — all drugs for Prostate Hyperplasia →
- Prostatic Hypertrophy — all drugs for Prostatic Hypertrophy →
- Surgery — all drugs for Surgery →
- Bladder Outlet Obstruction — all drugs for Bladder Outlet Obstruction →
Sponsor
Seoul National University Hospital
Who can join
Adults 50 to 90, male only, with Prostate Hyperplasia or Prostatic Hypertrophy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to prove that low-energy (30W) Holmium laser prostatectomy (Holeb) is not inferior to high-energy (100W) Holmium laser prostatectomy (safety and effectiveness)
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04514718
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Holmium laser
Trials testing the same drug.
- NCT02645058 — RIRS Versus ESWL for the Treatment of Renal Stones · NA · completed
Other recruiting trials for Prostate Hyperplasia
Currently open trials in the same condition.
- NCT06865430 — Management of Dysuria and Irritative Symptoms After HoLEP: a Prospective Study Evaluating the Efficacy of Alpha-Blocker · NA · recruiting
- NCT06834152 — Online Adaptive Stereotactic Body Radiotherapy for Localized Prostate Cancer (X-SMILE) · recruiting
- NCT06224218 — Prostate Single Port & Laser Enucleation Comparison Trial · NA · recruiting
- NCT05443451 — BETTY: BEnign Prostatic Hyperplasia Transperineal Targeted Microwave therapY · NA · recruiting
- NCT06116851 — Prostate Metabolism, Cancer Risk and Gut Microbiota · recruiting
Other Seoul National University Hospital trials
Trials by the same sponsor.
- NCT07262944 — EOI Block in Otoplasty With Rib Cartilage Graft · NA · recruiting
- NCT07464210 — Nemtabrutinib, Bortezomib, and Rituximab for WM · Phase 2 · not yet recruiting
- NCT07550803 — Effect of Intraoperative Dexamethasone on Early Postoperative Sleep Quality in Patients Undergoing Nasal Surgery · NA · not yet recruiting
- NCT07522138 — Home-based Self-exercise in Patients With Parkinson's Disease: A Feasibility Study · NA · not yet recruiting
- NCT07476651 — Scout Dose of Resin Microspheres · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04514718 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Seoul National University Hospital
- Last refreshed: 17 August 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04514718.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing